Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06576882
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-08-26
Brief Title:
7 Days Vs 14 Days of Vonoprazan-based Triple Therapy for H Pylori Eradication
Sponsor:
None
Organization:
None
Study Overview
Official Title:
7-day Versus 14-day Vonoprazan-based Triple Therapy for Eradication of H Pylori in Adolescents a Randomized Controlled Trial
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VOTE-HP
Brief Summary:
The study aims to test the efficacy of 7 days vs 14 days of Vonoprazan-triple therapy in the eradication of Helicobacter Pylori infection in adolescents and young children
Detailed Description:
After being informed about the study details all eligible participants or their legal guardians will give informed written consent to be involved After a one week screening eligible participants will be randomized to Vonoprazan plus Amoxicillin plus Clarithromycin triple therapy for either 14 days group 1 or 7 days group 2 at a 11 ratio After the end of therapy H Pylori eradication will be evaluated after 4 weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None